Portage Biotech (PRTG) Short Interest Ratio & Short Volume $5.96 +0.11 (+1.88%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Portage Biotech Short Interest DataPortage Biotech (PRTG) has a short interest of 9,400 shares, representing 2.22% of the float (the number of shares available for trading by the public). This marks a -6.93% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 638,429 shares to cover all short positions.Current Short Interest9,400 sharesPrevious Short Interest10,100 sharesChange Vs. Previous Month-6.93%Dollar Volume Sold Short$39,339.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares1,049,000 sharesFloat Size423,400 sharesShort Percent of Float2.22%Today's Trading Volume57,098 sharesAverage Trading Volume638,429 sharesToday's Volume Vs. Average9% Short Selling Portage Biotech? Sign up to receive the latest short interest report for Portage Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPRTG Short Interest Over TimePRTG Days to Cover Over TimePRTG Percentage of Float Shorted Over Time Ad Porter & CompanyVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Portage Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20249,400 shares $39,339.00 -6.9%2.2%0 $4.19 11/15/202410,100 shares $41,309.00 -30.3%2.4%0 $4.09 10/31/202414,500 shares $82,360.00 -22.9%3.4%0 $5.68 10/15/202418,800 shares $117,688.00 +6.8%4.4%0 $6.26 9/30/202417,600 shares $117,040.00 +87.2%4.2%0 $6.65 9/15/20249,400 shares $33,464.00 -80.2%2.2%0 $3.56 Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/31/202447,400 shares $163,530.00 +558.3%11.2%0.1 $3.45 8/15/20247,200 shares $25,200.00 -88.1%0.1%0 $3.50 7/31/202460,600 shares $10,671.66 -75.0%0.7%0.1 $0.18 7/15/2024242,000 shares $43,560.00 +1,628.6%2.8%0.3 $0.18 6/30/202414,000 shares $2,970.80 -74.5%0.2%0 $0.21 6/15/202454,900 shares $13,725.00 -9.3%0.6%0.2 $0.25 5/31/202460,500 shares $28,973.45 +2.2%0.7%0.2 $0.48 5/15/202459,200 shares $15,134.42 +2,473.9%0.7%0.3 $0.26 4/30/20242,300 shares $559.13 -72.6%0.0%0 $0.24 4/15/20248,400 shares $2,856.00 +29.2%0.1%0.1 $0.34 3/31/20246,500 shares $3,661.45 -57.8%0.1%0.1 $0.56 3/15/202415,400 shares $8,470.00 -84.6%0.2%0.2 $0.55 2/29/2024100,200 shares $59,118.00 +902.0%1.2%1.8 $0.59 2/15/202410,000 shares $6,005.00 -9.1%0.1%0.2 $0.60 1/31/202411,000 shares $9,571.10 +44.7%0.1%0.3 $0.87 1/15/20247,600 shares $8,208.00 +16.9%0.1%0.2 $1.08 12/31/20236,500 shares $11,830.00 -63.1%0.1%0.2 $1.82 12/15/202317,600 shares $22,352.00 -25.4%0.2%0.5 $1.27 11/30/202323,600 shares $31,034.00 -56.4%0.3%0.8 $1.32 11/15/202354,100 shares $78,445.00 +4.4%0.7%2 $1.45 10/31/202351,800 shares $102,823.00 -8.3%0.6%2.3 $1.99 10/15/202356,500 shares $119,780.00 +4.2%0.7%2.5 $2.12 9/30/202354,200 shares $113,278.00 +32.2%0.7%2.9 $2.09 9/15/202341,000 shares $118,490.00 +494.2%0.5%2.9 $2.89 8/31/20236,900 shares $17,664.00 -27.4%0.1%0.5 $2.56 8/15/20239,500 shares $22,800.00 +30.1%0.1%0.7 $2.40 7/31/20237,300 shares $23,506.00 +1.4%0.1%0.5 $3.22 7/15/20237,200 shares $24,408.00 +22.0%0.1%0.5 $3.39 6/30/20235,900 shares $20,591.00 -24.4%0.1%0.4 $3.49 6/15/20237,800 shares $28,860.00 -1.3%0.1%0.4 $3.70 5/31/20237,900 shares $27,492.00 -75.8%0.1%0.3 $3.48 5/15/202332,600 shares $104,646.00 -10.4%0.4%1.3 $3.21 4/30/202336,400 shares $121,576.00 -34.8%0.5%1.3 $3.34 4/15/202355,800 shares $175,770.00 +5.5%0.7%1.7 $3.15Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 3/31/202352,900 shares $163,461.00 +32.6%0.7%1.5 $3.09 3/15/202339,900 shares $119,700.00 -6.8%0.5%1.1 $3.00 2/28/202342,800 shares $163,496.00 -9.1%0.5%1.1 $3.82 2/15/202347,100 shares $198,762.00 -3.1%0.4%1.3 $4.22 1/31/202348,600 shares $250,290.00 +7.5%0.4%1.4 $5.15 1/15/202345,200 shares $246,150.16 -11.2%0.3%1.7 $5.45 12/30/202250,900 shares $269,261.00 +7.4%0.4%2.1 $5.29 12/15/202247,400 shares $237,000.00 -0.8%0.4%2.3 $5.00 11/30/202247,800 shares $281,064.00 +2.6%0.4%2.6 $5.88 11/15/202246,600 shares $280,066.00 +2.4%0.4%3.2 $6.01 10/31/202245,500 shares $298,935.00 -23.1%0.3%3.2 $6.57 10/15/202259,200 shares $400,192.00 +11.1%0.9%3.9 $6.76 9/30/202253,300 shares $363,506.00 +1.0%0.8%3.3 $6.82 9/15/202252,800 shares $414,480.00 -23.6%0.8%2 $7.85 8/31/202269,100 shares $532,761.00 +0.4%1.4%2.3 $7.71 8/15/202268,800 shares $580,672.00 -12.1%1.4%1.9 $8.44 7/31/202278,300 shares $792,396.00 +9.2%1.5%1.8 $10.12 7/15/202271,700 shares $646,017.00 -6.0%1.4%1.6 $9.01 6/30/202276,300 shares $532,574.00 -56.2%1.5%1.7 $6.98 6/15/2022174,100 shares $1.55 million -11.4%3.4%3.9 $8.93 5/31/2022196,500 shares $1.97 million -20.7%3.9%5.4 $10.00 5/15/2022247,900 shares $1.54 million +6.3%4.9%6.8 $6.20 4/30/2022233,200 shares $1.29 million +13.6%4.6%8.2 $5.54 4/15/2022205,300 shares $1.31 million +3.5%4.0%7.7 $6.39 3/31/2022198,400 shares $1.30 million +5.4%3.9%8.1 $6.57 3/15/2022188,200 shares $1.41 million +3.9%3.7%8.1 $7.51 2/28/2022181,100 shares $1.44 million +11.5%3.6%7.8 $7.95 2/15/2022162,400 shares $1.44 million +9.5%3.2%6.7 $8.84 1/31/2022148,300 shares $1.29 million +1.4%2.9%6 $8.68 1/15/2022146,200 shares $1.54 million +2.2%2.9%5.6 $10.54 12/31/2021143,100 shares $1.54 million +12.8%2.9%5.7 $10.73 12/15/2021126,900 shares $1.54 million +3.9%2.6%5.2 $12.13 11/30/2021122,200 shares $1.80 million -9.3%2.5%4.5 $14.73 11/15/2021134,700 shares $2.94 million -9.5%2.8%5.6 $21.86 10/29/2021148,800 shares $3.04 million +3.1%3.0%6.1 $20.40 10/15/2021144,400 shares $3.00 million -8.5%3.0%5.4 $20.79 9/30/2021157,800 shares $3.21 million +0.9%3.2%4.8 $20.32 9/15/2021156,400 shares $2.97 million -10.1%3.2%2.2 $18.97 8/31/2021174,000 shares $3.53 million -0.7%3.6%2.4 $20.31 8/13/2021175,200 shares $3.03 million No Change3.6%2.4 $17.32 PRTG Short Interest - Frequently Asked Questions What is Portage Biotech's current short interest? Short interest is the volume of Portage Biotech shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 9,400 shares of PRTG short. 2.22% of Portage Biotech's shares are currently sold short. Learn More on Portage Biotech's current short interest. What is a good short interest percentage for Portage Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.22% of Portage Biotech's floating shares are currently sold short. Is Portage Biotech's short interest increasing or decreasing? Portage Biotech saw a decline in short interest in November. As of November 30th, there was short interest totaling 9,400 shares, a decline of 6.9% from the previous total of 10,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Portage Biotech's float size? Portage Biotech currently has issued a total of 1,049,000 shares. Some of Portage Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Portage Biotech currently has a public float of 423,400 shares. How does Portage Biotech's short interest compare to its competitors? 2.22% of Portage Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Portage Biotech: Acurx Pharmaceuticals, Inc. (3.22%), TherapeuticsMD, Inc. (0.19%), HCW Biologics Inc. (0.65%), Marinus Pharmaceuticals, Inc. (7.94%), PharmaCyte Biotech, Inc. (0.75%), Kazia Therapeutics Limited (0.51%), Sol-Gel Technologies Ltd. (0.70%), Aspira Women's Health Inc. (4.33%), ANEW Medical, Inc. (1.67%), CervoMed Inc. (35.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Portage Biotech stock? Short selling PRTG is an investing strategy that aims to generate trading profit from Portage Biotech as its price is falling. PRTG shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Portage Biotech? A short squeeze for Portage Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTG, which in turn drives the price of the stock up even further. How often is Portage Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTG, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ACXP Short Squeeze TXMD Short Squeeze HCWB Short Squeeze MRNS Short Squeeze PMCB Short Squeeze KZIA Short Squeeze SLGL Short Squeeze AWH Short Squeeze WENA Short Squeeze CRVO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
